| AASLD

Letter to the editor: Autoimmune hepatitis after COVID‐19 vaccination: A rare adverse effect?

Read more about Letter to the editor: Autoimmune hepatitis after COVID‐19 vaccination: A rare adverse effect?

Panagiota Palla, Chrysovalantis Vergadis, Stratigoula Sakellariou, Theodoros Androutsakos – 14 September 2021

Masthead

Read more about Masthead

14 September 2021

Instructions to Authors

Read more about Instructions to Authors

14 September 2021

Frailty is associated with increased risk of cirrhosis disease progression and death

Read more about Frailty is associated with increased risk of cirrhosis disease progression and death

Sarah Wang, Reid Whitlock, Chelsea Xu, Sunil Taneja, Surender Singh, Juan G. Abraldes, Kelly W. Burak, Robert J. Bailey, Jennifer C. Lai, Puneeta Tandon – 14 September 2021

Cover Image

Read more about Cover Image

14 September 2021

Read more about Table of contents

14 September 2021

Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial

Read more about Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial

Björn Nashan, Peter Schemmer, Felix Braun, Hans J. Schlitt, Andreas Pascher, Christian G. Klein, Ulf P. Neumann, Irena Kroeger, Peter Wimmer, Hephaistos Study Group – 14 September 2021 – Everolimus‐facilitated reduced‐exposure tacrolimus (EVR + rTAC) at 30 days after liver transplantation (LT) has shown advantages in renal preservation. This study evaluated the effects of early initiation of EVR + rTAC in de novo LT recipients (LTRs).

Hepatology Highlights

Read more about Hepatology Highlights

Iman Waheed Khan, Muhammad Ashar Ali, Daryl T.Y. Lau, Thuy‐Van P. Hang, Preeti A. Reshamwala, Nidhi Jalan‐Sakrikar, Robert E. Schwartz, Shalil Khanal, Enis Kostallari, Anthony J. Choi, Robert S. Brown, Adebowale O. Bamidele, Davide Povero, Wei Zhang, Alyson Kaplan, Jeremy Louissaint, Nabeel Wahid, Jessica L. Maiers – 14 September 2021